Regions Financial Corp Amgen Inc Transaction History

Regions Financial Corp

  • $13.1 Billion
  • Q2 2024

A detailed history of Regions Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Regions Financial Corp holds 14,742 shares of AMGN stock, worth $4.66 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,742
Previous 16,526 10.8%
Holding current value
$4.66 Million
Previous $4.7 Million 1.96%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$262.75 - $319.31 $468,746 - $569,649
-1,784 Reduced 10.8%
14,742 $4.61 Million
Q1 2024

Apr 23, 2024
SELL
$268.87 - $324.56 $93,297 - $112,622
-347 Reduced 2.06%
16,526 $4.7 Million
Q4 2023

Feb 06, 2024
SELL
$255.7 - $288.46 $6,136 - $6,923
-24 Reduced 0.14%
16,873 $4.86 Million
Q3 2023

Nov 01, 2023
SELL
$218.65 - $271.46 $103,858 - $128,943
-475 Reduced 2.73%
16,897 $4.54 Million
Q2 2023

Aug 09, 2023
SELL
$214.27 - $253.37 $1.08 Million - $1.28 Million
-5,046 Reduced 22.51%
17,372 $3.86 Million
Q1 2023

May 12, 2023
BUY
$225.79 - $275.2 $39,513 - $48,160
175 Added 0.79%
22,418 $5.42 Million
Q4 2022

Feb 03, 2023
SELL
$229.03 - $291.01 $221,013 - $280,824
-965 Reduced 4.16%
22,243 $5.84 Million
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $304,143 - $343,018
-1,355 Reduced 5.52%
23,208 $5.23 Million
Q2 2022

Jul 25, 2022
SELL
$230.71 - $256.74 $348,372 - $387,677
-1,510 Reduced 5.79%
24,563 $5.98 Million
Q1 2022

Apr 25, 2022
BUY
$219.27 - $242.57 $8,770 - $9,702
40 Added 0.15%
26,073 $6.31 Million
Q4 2021

Jan 31, 2022
SELL
$198.88 - $227.6 $363,950 - $416,508
-1,830 Reduced 6.57%
26,033 $5.86 Million
Q3 2021

Nov 04, 2021
SELL
$212.27 - $248.7 $553,600 - $648,609
-2,608 Reduced 8.56%
27,863 $5.93 Million
Q2 2021

Jul 27, 2021
BUY
$233.58 - $259.14 $148,790 - $165,072
637 Added 2.14%
30,471 $7.43 Million
Q1 2021

Jun 02, 2021
SELL
$221.91 - $258.6 $141,134 - $164,469
-636 Reduced 2.09%
29,834 $7.42 Million
Q4 2020

Feb 05, 2021
BUY
$216.38 - $257.67 $399,437 - $475,658
1,846 Added 6.45%
30,470 $7.01 Million
Q3 2020

Oct 15, 2020
SELL
$234.65 - $260.95 $42,940 - $47,753
-183 Reduced 0.64%
28,624 $7.28 Million
Q2 2020

Jul 27, 2020
BUY
$197.81 - $242.74 $144,994 - $177,928
733 Added 2.61%
28,807 $6.8 Million
Q1 2020

Apr 29, 2020
SELL
$182.24 - $241.7 $155,815 - $206,653
-855 Reduced 2.96%
28,074 $5.69 Million
Q4 2019

Feb 03, 2020
SELL
$189.21 - $243.2 $63,952 - $82,201
-338 Reduced 1.15%
28,929 $6.97 Million
Q3 2019

Oct 24, 2019
BUY
$174.11 - $208.62 $64,420 - $77,189
370 Added 1.28%
29,267 $5.66 Million
Q2 2019

Jul 19, 2019
SELL
$166.7 - $195.41 $178,869 - $209,674
-1,073 Reduced 3.58%
28,897 $5.33 Million
Q1 2019

Apr 19, 2019
SELL
$180.87 - $203.88 $227,172 - $256,073
-1,256 Reduced 4.02%
29,970 $5.69 Million
Q4 2018

Jan 28, 2019
SELL
$178.4 - $208.25 $1,427 - $1,666
-8 Reduced 0.03%
31,226 $6.08 Million
Q3 2018

Oct 22, 2018
SELL
$185.29 - $208.89 $2.26 Million - $2.55 Million
-12,214 Reduced 28.11%
31,234 $6.47 Million
Q2 2018

Jul 26, 2018
SELL
$166.05 - $186.51 $1.96 Million - $2.21 Million
-11,829 Reduced 21.4%
43,448 $8.02 Million
Q1 2018

Apr 18, 2018
BUY
$169.43 - $198.0 $89,459 - $104,544
528 Added 0.96%
55,277 $9.42 Million
Q4 2017

Jan 18, 2018
BUY
$168.79 - $188.59 $282,216 - $315,322
1,672 Added 3.15%
54,749 $9.52 Million
Q3 2017

Oct 23, 2017
BUY
$167.29 - $191.0 $8.88 Million - $10.1 Million
53,077
53,077 $9.9 Million

Others Institutions Holding AMGN

# of Institutions
3,073
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email